Nathan Rice
Stock Analyst at Piper Sandler
(3.02)
# 1,337
Out of 5,113 analysts
60
Total ratings
52.63%
Success rate
9.9%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $41.17 | +16.59% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $35.11 | +19.62% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $30.51 | +14.72% | 9 | Oct 28, 2025 | |
| BFC Bank First | Maintains: Neutral | $137 → $142 | $132.47 | +7.19% | 9 | Oct 23, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $77.72 | -4.79% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $128.48 | -34.62% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $157.69 | +24.93% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $22.30 | -59.64% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $700.34 | -37.89% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $271.89 | -14.30% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $39.02 | +112.71% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $20.53 | -26.94% | 1 | Dec 19, 2019 |
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $41.17
Upside: +16.59%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $35.11
Upside: +19.62%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $30.51
Upside: +14.72%
Bank First
Oct 23, 2025
Maintains: Neutral
Price Target: $137 → $142
Current: $132.47
Upside: +7.19%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $77.72
Upside: -4.79%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $128.48
Upside: -34.62%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $157.69
Upside: +24.93%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $22.30
Upside: -59.64%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $700.34
Upside: -37.89%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $271.89
Upside: -14.30%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $39.02
Upside: +112.71%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $20.53
Upside: -26.94%